These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16868831)

  • 1. Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis.
    Gaddipati KV; Simonian HP; Kresge KM; Boden GH; Parkman HP
    Dig Dis Sci; 2006 Aug; 51(8):1339-46. PubMed ID: 16868831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of sham feeding and meal ingestion on ghrelin and pancreatic polypeptide levels: evidence for vagal efferent stimulation mediating ghrelin release.
    Simonian HP; Kresge KM; Boden GH; Parkman HP
    Neurogastroenterol Motil; 2005 Jun; 17(3):348-54. PubMed ID: 15916622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study.
    Murray CD; Martin NM; Patterson M; Taylor SA; Ghatei MA; Kamm MA; Johnston C; Bloom SR; Emmanuel AV
    Gut; 2005 Dec; 54(12):1693-8. PubMed ID: 16085693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of modified sham feeding on ghrelin levels in healthy human subjects.
    Arosio M; Ronchi CL; Beck-Peccoz P; Gebbia C; Giavoli C; Cappiello V; Conte D; Peracchi M
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5101-4. PubMed ID: 15472212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study.
    Ejskjaer N; Dimcevski G; Wo J; Hellström PM; Gormsen LC; Sarosiek I; Søfteland E; Nowak T; Pezzullo JC; Shaughnessy L; Kosutic G; McCallum R
    Neurogastroenterol Motil; 2010 Oct; 22(10):1069-e281. PubMed ID: 20524987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-induced incretin hormone release and insulin sensitivity are impaired in patients with idiopathic gastroparesis: results from a pilot descriptive study.
    Prévost G; Ducrotté P; Cailleux A; Khalfi K; Basuyau JP; Lefebvre H; Kuhn JM
    Neurogastroenterol Motil; 2013 Aug; 25(8):694-9. PubMed ID: 23663508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ghrelin agonist fails to show benefit in patients with diabetic gastroparesis: let's not throw the baby out with the bath water.
    Camilleri M; Acosta A
    Neurogastroenterol Motil; 2013 Nov; 25(11):859-63. PubMed ID: 24001134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cephalic-vagal stimulation on insulin, gastric inhibitory polypeptide, and pancreatic polypeptide release in humans.
    Taylor IL; Feldman M
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1114-7. PubMed ID: 6752165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of ghrelin and growth hormone releasing peptide 6 on gastroparesis in streptozotocin-induced diabetic guinea pigs in vivo and in vitro.
    Qiu WC; Wang ZG; Wang WG; Yan J; Zheng Q
    Chin Med J (Engl); 2008 Jul; 121(13):1183-8. PubMed ID: 18710636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin gastrokinetic action in patients with neurogenic gastroparesis.
    Binn M; Albert C; Gougeon A; Maerki H; Coulie B; Lemoyne M; Rabasa Lhoret R; Tomasetto C; Poitras P
    Peptides; 2006 Jul; 27(7):1603-6. PubMed ID: 16426704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesis.
    McCallum RW; Lembo A; Esfandyari T; Bhandari BR; Ejskjaer N; Cosentino C; Helton N; Mondou E; Quinn J; Rousseau F;
    Neurogastroenterol Motil; 2013 Nov; 25(11):e705-17. PubMed ID: 23848826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ghrelin on gastric emptying and meal-related symptoms in idiopathic gastroparesis.
    Tack J; Depoortere I; Bisschops R; Verbeke K; Janssens J; Peeters T
    Aliment Pharmacol Ther; 2005 Nov; 22(9):847-53. PubMed ID: 16225494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric motor effects of ghrelin and growth hormone releasing peptide 6 in diabetic mice with gastroparesis.
    Qiu WC; Wang ZG; Wang WG; Yan J; Zheng Q
    World J Gastroenterol; 2008 Mar; 14(9):1419-24. PubMed ID: 18322959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A safe and noninvasive test for vagal integrity revisited.
    Balaji NS; Crookes PF; Banki F; Hagen JA; Ardill JE; DeMeester TR
    Arch Surg; 2002 Aug; 137(8):954-8; discussion 958-9. PubMed ID: 12146997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of atropine on vagal release of gastrin and pancreatic polypeptide.
    Feldman M; Richardson CT; Taylor IL; Walsh JH
    J Clin Invest; 1979 Feb; 63(2):294-8. PubMed ID: 429555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired pancreatic polypeptide response to a meal in type 1 diabetic patients: vagal neuropathy or islet cell dysfunction?
    Rasmussen MH; Carstensen H; List S; Schwartz TW; Hilsted J
    Acta Endocrinol (Copenh); 1993 Mar; 128(3):221-4. PubMed ID: 8480470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-blinded, randomized pilot study evaluating effects of electroacupuncture in diabetic patients with symptoms suggestive of gastroparesis.
    Wang CP; Kao CH; Chen WK; Lo WY; Hsieh CL
    J Altern Complement Med; 2008 Sep; 14(7):833-9. PubMed ID: 18721079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No ghrelin response to oral glucose in diabetes mellitus with gastroparesis.
    Asai S; Katabami T; Obi N; Matsui T; Kato H; Obi R; Ogawa Y; Kawata T; Takama H; Ohta A; Tanaka Y
    Endocr J; 2009; 56(1):79-87. PubMed ID: 18946177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin improves expression of ghrelin through attenuating oxidative stress in gastric tissues of streptozotocin-induced diabetic gastroparesis rats.
    Xu L; Li Z; Guo F
    Eur J Pharmacol; 2013 Oct; 718(1-3):219-25. PubMed ID: 24036253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis.
    Ejskjaer N; Vestergaard ET; Hellström PM; Gormsen LC; Madsbad S; Madsen JL; Jensen TA; Pezzullo JC; Christiansen JS; Shaughnessy L; Kosutic G
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1179-87. PubMed ID: 19298585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.